Analyst Ratings for BioMarin Pharmaceutical Inc. (BMRN)
BMRN Rating Summary
BMRN Price Target Summary
- Highest: $200.00 (BofA Securities)
- Lowest: $74.00 (Wedbush)
- Average: $118.44
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$118.44 (+25.7%)
* Over Last 12-Mos
Rating Score: 6.8 / 10
Percentile Rank: 74%
Avg. $ Target:
$118.44 (+25.7%)
* Over Last 12-Mos
Rating Score: 6.8 / 10
Percentile Rank: 74%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/21/2023 | Bernstein | William Pickering | New Coverage | Underperform (N/A) |
81.00 (N/A) |
91.67 (94.20) |
2.76% | Details |
| 2/22/2023 | Oppenheimer | Leland Gershell | Downgrade | Perform (Outperform) |
N/A (N/A) |
105.97 (94.20) |
-11.11% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
